Supra-aortic low-dose contrast-enhanced time-resolved magnetic resonance (MR) angiography at 3 T: comparison with time-of-flight MR angiography and high-resolution contrast-enhanced MR angiography

Abstract

Background

Low-dose, time-resolved, contrast-enhanced, magnetic resonance angiography (TR-CEMRA) has been described previously; however, a comparative study between low dose TR-CEMRA and time-of-flight MRA (TOF-MRA) in the diagnosis of supra-aortic arterial stenosis has not yet been published.

Purpose

To demonstrate the feasibility and effectiveness of low-dose TR-CEMRA compared with TOF-MRA, using high-resolution contrast-enhanced MRA (HR-CEMRA) as the reference standard.

Material and Methods

This prospective study consisted of 30 consecutive patients. All patients underwent TOF-MRA of the neck and circle of Willis and supra-aortic HR-CEMRA, followed by supra-aortic low-dose TR-CEMRA. Gadoterate meglumine (Gd-DOTA, Dotarem®, Guerbet, Roissy CdG Cedex, France) was injected at a dose of 0.1 mmol/kg for HR-CEMRA, followed by a 0.03 mmol/kg bolus for low-dose TR-CEMRA. Three readers evaluated the assessibility and image quality, and then two readers classified each stenosis into the following categories: normal (0–30%), mild stenosis (31–50%), moderate (51–70%), severe (71–99%), and occlusion.

Results

TR-CEMRA and HR-CEMRA showed a greater number of assessable arterial segments than TOF-MRA (P < 0.01). For TR-CEMRA, 29 cases showed within or better than the diagnostic range, whereas all 30 cases were in the diagnostic range for TOF-MRA and HR-CEMRA. For evaluation of stenosis in a total of 743 arterial segments, both TR-CEMRA and TOF-MRA results agreed with those of HR-CEMRA in 729 segments (98.1%), with excellent inter-observer agreement of TR-CEMRA; stenosis was overestimated in nine segments (1.2%) and underestimated in five segments (0.7%). For diagnosis of stenosis using 30% as the cut-off value on HR-CEMRA, the sensitivity and specificity were 88.2% and 99.3%, respectively, for the TR-CEMRA procedure, versus 94.1% and 99.6%, respectively, for TOF-MRA.

Conclusion

Low-dose TR-CEMRA is feasible and effective in the diagnosis of supra-aortic arterial stenosis, and could be more useful option than TOF-MRA.

Keywords

Magnetic resonance angiography contrast media supraaortic artery

Get full access to this article

View all access options for this article.

References

Remonda

Senn

Barth

. Contrast-enhanced 3D MR angiography of the carotid artery: comparison with conventional digital subtraction angiography. Am J Neuroradiol 2002; 23: 213–219.

Villablanca

Nael

Habibi

. 3T contrast-enhanced magnetic resonance angiography for evaluation of the intracranial arteries: comparison with time-of-flight magnetic resonance angiography and multislice computed tomography angiography. Invest Radiol 2006; 41: 799–805.

Willinek

Bayer

Gieseke

. High spatial resolution contrast-enhanced MR angiography of the supra-aortic arteries using the quadrature body coil at 3.0T: a feasibility study. Eur Radiol 2007; 17: 618–625.

Korosec

Frayne

Grist

. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996; 36: 345–351.

Razek

Gaballa

Megahed

. Time resolved imaging of contrast kinetics (TRICKS) MR angiography of arteriovenous malformations of head and neck. Eur J Radiol 2013; 82: 1885–1891.

Yiğit

Turan

Ergün

. Time-resolved MR angiography of the intracranial venous system: an alternative MR venography technique. Eur Radiol 2012; 22: 980–989.

Grist

Mistretta

Strother

. Time-resolved angiography: Past, present, and future. J Magn Reson Imaging 2012; 36: 1273–1286.

Machet

Portefaix

Kadziolka

. Brain arteriovenous malformation diagnosis: value of time-resolved contrast-enhanced MR angiography at 3.0T compared to DSA. Neuroradiology 2012; 54: 1099–1108.

Rydahl

Thomsen

Marckmann

. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent. Invest Radiol 2008; 43: 141–144.

10.

Hedley

Molan

Hare

. Nephrogenic systemic fibrosis associated with gadolinium-containing contrast media administration in patients with reduced glomerular filtration rate. Nephrology 2007; 12: 111–111.

11.

Sadowski

Bennett

Chan

. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243: 148–157.

12.

Frayne

Grist

Swan

. 3D MR DSA: effects of injection protocol and image masking. J Magn Reson Imaging 2000; 12: 476–487.

13.

Lim

Shapiro

Wang

. 3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced Bolus-Chase MRA and 3D time-of-flight MRA. Am J Neuroradiol 2008; 29: 1847–1854.

14.

Mohrs

Petersen

Voigtlaender

. Time-resolved contrast-enhanced MR angiography of the thorax in adults with congenital heart disease. Am J Roentgenol 2006; 187: 1107–1114.

15.

Krishnam

Tomasian

Lohan

. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA. Clin Radiol 2008; 63: 744–755.

16.

Nederkoorn

van der Graaf

Eikelboom

. Time-of-flight MR angiography of carotid artery stenosis: does a flow void represent severe stenosis? Am J Neuroradiol 2002; 23: 1779–1784.

17.

Kang

Lim

Choi

. Evaluation of contrast-enhanced magnetic resonance angiography (MRA) using Gd-DOTA compared with time-of-flight MRA in the diagnosis of clinically significant non-coronary arterial disease. Eur Radiol 2010; 20: 1934–1944.

18.

Nael

Moriarty

Finn

. Low dose CE-MRA. Eur J Radiol 2011; 80: 2–8.

19.

Lohan

Tomasian

Saleh

. Ultra-low-dose, time-resolved contrast-enhanced magnetic resonance angiography of the carotid arteries at 3.0 tesla. Invest Radiol 2009; 44: 207–217.